4 European Projects Found
Searched on 125080 European Projects
FINISHED
A multi-center randomized, placebo-controlled trial of mirabegron, a new beta3-adrenergic receptor agonist on left ventricular mass and diastolic function in patients with structural heart disease (BETA3_LVH)
Start date: May 1, 2015, End date: Apr 30, 2020,
Patients with cardiovascular risk factors, e.g. hypertension and obesity are at risk of developing heart failure with preserved ejection fraction (HFpEF), a highly prevalent disease in the elderly, mostly women population. There is currently no specific, defined treatment for HFpEF, beyond control of risk factors. Activation of cardiac and vascular Beta3-adrenergic receptors (B3AR) represents a ne ...
Read Project
15
Partners Participants
FINISHED
Novel Stromal Cell Therapy for Diabetic Kidney Disease (NEPHSTROM)
Start date: May 1, 2015, End date: Apr 30, 2019,
Type 2 diabetes will affect >500 million adults by 2040 and its secondary complications will generate enormous socioeconomic costs - in particular, diabetic kidney disease (DKD), which is already the most common cause of chronic kidney disease. DKD is associated with greatly increased mortality and frequently progresses to end stage renal failure. Pharmacotherapy, dialysis and transplantation repr ...
Read Project
12
Partners Participants
FINISHED
Stem-cell based therapy for kidney repair (STELLAR)
Start date: Nov 1, 2012, End date: Oct 31, 2017,
Chronic kidney disease (CKD) affects 8% of the European population and ultimately results in renal failure due to progressive fibrosis. CDK carries a high mortality risk and the number of affected people rises, increasing the demand on renal replacement therapies while the number of available donor organs stays stable.The STELLAR consortium proposes to develop an alternative to renal replacement ...
Read Project
15
Partners Participants
FINISHED
PREvention of Late Stent Thrombosis by an Interdisciplinary Global European effort (PRESTIGE)
Start date: Dec 1, 2010, End date: Nov 30, 2014,
"According to the European Society of Cardiology there has been an increase in the life expectancy at the age of 65 of the European population from 15.0 to 17.0 years in the years since 1980. In the elderly, up to 50% of deaths are caused by cardiovascular diseases, the majority accounted for by coronary artery disease. The most effective treatment for obstructive coronary disease is percutaneous ...
Read Project
